SGLT2-i improves DCM by affecting the miR-30d/KLF9/VEGFA pathway, which regulates the expression of autophagy factors protein light chain 3 (LC3-II) and p62/SQSTM1 (p62/sequestosome 1). Here, SQSTM1 is linked to familial dilated cardiomyopathy.